Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.
- Published In:
- Cardiovascular diabetology, 18(1), 73 (2019)
- Authors:
- Leiter, Lawrence A(4), Bain, Stephen C(9), Hramiak, Irene, Jódar, Esteban, Madsbad, Sten, Gondolf, Theis, Hansen, Thomas, Holst, Ingrid, Lingvay, Ildiko
- Database ID:
- RPEP-04316
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04316APA
Leiter, Lawrence A; Bain, Stephen C; Hramiak, Irene; Jódar, Esteban; Madsbad, Sten; Gondolf, Theis; Hansen, Thomas; Holst, Ingrid; Lingvay, Ildiko. (2019). Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.. Cardiovascular diabetology, 18(1), 73. https://doi.org/10.1186/s12933-019-0871-8
MLA
Leiter, Lawrence A, et al. "Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.." Cardiovascular diabetology, 2019. https://doi.org/10.1186/s12933-019-0871-8
RethinkPeptides
RethinkPeptides Research Database. "Cardiovascular risk reduction with once-weekly semaglutide i..." RPEP-04316. Retrieved from https://rethinkpeptides.com/research/leiter-2019-cardiovascular-risk-reduction-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.